China Risun Group (1907) H1 2026 earnings summary
Event summary combining transcript, slides, and related documents.
H1 2026 earnings summary
28 Sep, 2026Executive summary
Revenue rose 5.2% year-over-year to RMB21,855.9 million, with net profit surging 376.0% to RMB244.4 million and basic EPS up 736.8% to RMB4.77 cents, driven by higher product prices and improved segment margins.
Interim dividend declared at RMB1.44 cents per share, up from RMB0.20 cents last year, representing over 30% of net profit attributable to owners.
Major acquisition of 14.5% in Binhai Energy, expanding into new energy battery materials and consolidating Binhai as a subsidiary.
Production volumes for coke, refined chemicals, and high-purified hydrogen declined year-over-year, while lithium battery anode materials output increased 63.9%.
Financial highlights
Gross profit increased 37.7% year-over-year to RMB2,311.3 million, with gross margin rising to 10.6% from 8.1%.
EBITDA margin reached 9.8%, up from 8.9% last year.
Net profit margin improved to 1.1% from 0.2% year-over-year.
Return on equity rose to 3.4% from 0.4%.
Total borrowings increased 18.5% to RMB41,401.1 million as of June 30, 2026, with gearing ratio at 78.5%.
Net cash from operating activities was RMB2,526.7 million, up from RMB1,861.3 million.
Outlook and guidance
Focus on expanding silicon-carbon and porous carbon material production lines, integrated anode material projects, and hydrogen energy infrastructure in H2 2026.
Plans to further develop hydrogen energy infrastructure and battery materials, leveraging cost and supply chain advantages.
Strategic goal to enhance market share in coke, refined chemicals, and new energy products through M&A, joint ventures, and new project launches.
Continued R&D and production of high-value refined chemicals and expansion of hydrogen energy supply chain.
Plans to increase coke sales and implement price increments as market conditions allow.
Latest events from China Risun Group
- Net profit surged 37.7% despite a 17.4% revenue drop, with improved margins and expanded capacity.1907
H2 2025 - Revenue up 21% but net profit down 84% as margins tighten and leverage rises.1907
H1 2024 - Revenue up, profit down sharply; refined chemicals and management segments drive growth.1907
H2 2024 - Revenue and profit fell despite higher production; focus shifts to innovation and hydrogen energy.1907
H1 2025